Public Employees Retirement Association of Colorado cut its position in Humana Inc (NYSE:HUM) by 0.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 25,477 shares of the insurance provider’s stock after selling 58 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Humana were worth $7,299,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of the business. Capital International Investors raised its holdings in shares of Humana by 3,030.3% during the third quarter. Capital International Investors now owns 8,217,296 shares of the insurance provider’s stock valued at $2,781,719,000 after purchasing an additional 7,954,786 shares during the last quarter. Intact Investment Management Inc. purchased a new position in shares of Humana during the third quarter valued at approximately $220,000. Palo Capital Inc. purchased a new position in shares of Humana during the third quarter valued at approximately $178,000. Monument Capital Management purchased a new position in shares of Humana during the fourth quarter valued at approximately $1,809,000. Finally, Artemis Investment Management LLP raised its holdings in shares of Humana by 74.6% during the third quarter. Artemis Investment Management LLP now owns 262,042 shares of the insurance provider’s stock valued at $88,676,000 after purchasing an additional 111,991 shares during the last quarter. 92.23% of the stock is owned by institutional investors and hedge funds.
A number of brokerages have commented on HUM. upped their target price on shares of Humana from $350.00 to $373.00 and gave the company an “outperform” rating in a report on Thursday, November 8th. Cowen raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $275.02 target price for the company in a report on Friday, January 11th. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $327.00 target price for the company in a report on Thursday, December 20th. Royal Bank of Canada upped their target price on shares of Humana from $318.00 to $349.00 and gave the company a “sector perform” rating in a report on Thursday, November 8th. Finally, JPMorgan Chase & Co. raised shares of Humana from a “neutral” rating to an “overweight” rating and set a $283.00 target price for the company in a report on Thursday, December 20th. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Humana currently has a consensus rating of “Buy” and a consensus price target of $355.06.
In other Humana news, insider Heidi S. Margulis sold 2,656 shares of the company’s stock in a transaction that occurred on Tuesday, December 18th. The shares were sold at an average price of $296.22, for a total value of $786,760.32. Following the completion of the transaction, the insider now directly owns 10,371 shares in the company, valued at $3,072,097.62. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Roy A. Beveridge sold 8,278 shares of the company’s stock in a transaction that occurred on Tuesday, February 19th. The stock was sold at an average price of $307.16, for a total transaction of $2,542,670.48. Following the completion of the transaction, the insider now owns 12,409 shares of the company’s stock, valued at $3,811,548.44. The disclosure for this sale can be found here. Corporate insiders own 0.60% of the company’s stock.
HUM opened at $309.68 on Friday. The company has a market capitalization of $41.98 billion, a price-to-earnings ratio of 21.28, a PEG ratio of 1.28 and a beta of 1.05. Humana Inc has a 1-year low of $261.35 and a 1-year high of $355.88. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.68 and a quick ratio of 1.68.
Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, February 6th. The insurance provider reported $2.65 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.53 by $0.12. The business had revenue of $14.17 billion during the quarter, compared to analyst estimates of $14.04 billion. Humana had a net margin of 2.96% and a return on equity of 19.64%. The company’s revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the business posted $2.06 earnings per share. Equities research analysts anticipate that Humana Inc will post 17.49 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be given a $0.55 dividend. This is a positive change from Humana’s previous quarterly dividend of $0.50. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date of this dividend is Thursday, March 28th. Humana’s dividend payout ratio is presently 6.87%.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Featured Story: Quick Ratio
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.